Therapeutic improvements expected in the near future for schizophrenia and schizoaffective disorder: an appraisal of phase III clinical trials of schizophrenia-targeted therapies as found in US and EU clinical trial registries - Université Clermont Auvergne
Article Dans Une Revue Expert Opinion on Pharmacotherapy Année : 2016

Therapeutic improvements expected in the near future for schizophrenia and schizoaffective disorder: an appraisal of phase III clinical trials of schizophrenia-targeted therapies as found in US and EU clinical trial registries

Domaines

Neurosciences Neurobiologie Psychologie et comportements Sciences cognitives

Marie-Laurence Douhairie  : Connectez-vous pour contacter le contributeur

https://uca.hal.science/hal-02174673

Soumis le : vendredi 5 juillet 2019-11:36:40

Dernière modification le : lundi 30 septembre 2024-12:16:27

Fichier non déposé

Dates et versions

hal-02174673 , version 1 (05-07-2019)

Identifiants

Citer

Ricardo P Garay, Leslie Citrome, Ludovic Samalin, Chen-Chung Liu, Morten Thomsen, et al.. Therapeutic improvements expected in the near future for schizophrenia and schizoaffective disorder: an appraisal of phase III clinical trials of schizophrenia-targeted therapies as found in US and EU clinical trial registries. Expert Opinion on Pharmacotherapy, 2016, 17 (7), pp.921-936. ⟨10.1517/14656566.2016.1149164⟩. ⟨hal-02174673⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

PRES_CLERMONT
57 Consultations
1 Téléchargements

Altmetric

Partager

More